-
2024-511950-35-00
5
2025-06-12
Acute Myocardial Infarction
-
2024-515593-27-00
5
2025-05-08
relapsed or refractory mantle cell lymphoma (R/R MCL)
-
2024-513053-69-00
5
2025-04-16
Moderately to Severely Active Crohn's Disease (CD)
-
2022-501489-24-00
5
2025-03-28
First-line treatment of adult subjects with high-risk large B-cell lym
-
2023-506998-35-00
5
2025-01-08
Glioblastoma
-
2024-511188-26-00
5
2024-12-20
Relapsed/refractory multiple myeloma in patients who have received 1 t
-
2023-507332-20-00
9
2024-12-18
Dupuytren contracture
-
2023-508813-18-00
4
2024-12-18
Refractory Focal Onset Epilepsy
-
2023-509912-27-00
5
2024-11-07
Metabolic Dysfunction-Associated Steatotic Liver Disease(MASH) / Nonal
-
2023-508539-30-00
4
2024-10-10
Refractory Focal Onset Epilepsy
-
2023-506613-22-00
5
2024-09-25
coronary artery disease
-
2023-508162-15-00
5
2024-07-12
Chronic HF and comorbid impairment of kidney function who had a recent
-
2023-508158-24-00
4
2024-06-25
Moderately to Severely Active Crohn’s Disease
-
2023-505436-35-00
5
2024-06-03
Untreated FLIPI 2-5 Follicular Lymphoma
-
2022-501119-14-01
4
2024-04-16
Ulcerative Colitis
-
2022-502113-28-00
5
2024-02-01
Follicular lymphoma
-
2022-501515-14-00
5
2023-09-29
Newly Diagnosed Multiple Myeloma (NDMM)
-
2023-504973-19-01
5
2023-09-06
early-stage, intermediate-risk cervical cancer
-
2022-501899-26-00
5
2023-09-01
Asthma
-
2022-500967-11-00
5
2023-07-06
Previously Untreated Metastatic or Unresectable Melanoma
-
2023-504599-10-00
4
2022-03-29
Chronic lymphocytic leukemia recurrent
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2024-515229-26-00
5
2021-05-21
eosinophilic esophagitis
-
2023-507689-26-00
5
2019-10-07
Histologically or cytologically confirmed Locoregional Hepatocellular